Results 261 to 270 of about 40,821 (327)

Endothelin Receptor Antagonists for the Treatment of Hypertension: Recent Data from Clinical Trials and Implementation Approach. [PDF]

Curr Cardiol Rep
Manickavasagar R, Krishnan A, Azzam O, Schlaich MP.   +3 more
europepmc   +1 more source

Transient Receptor Potential (TRP) Channels as Fundamental Regulators of Fibrosis and Pruritus-A New Therapeutic Target for Pathological Scar Management. [PDF]

Int J Mol Sci
Tang Y, Zhang Z, Zhang Y.
europepmc   +1 more source

G Protein-Coupled Receptors in Cerebrovascular Diseases: Signaling Mechanisms and Therapeutic Opportunities. [PDF]

Int J Mol Sci
Gu Q, Yao J, Sheng J, Liu D.
europepmc   +1 more source

Mechanism of the analgesic effect of electroacupuncture on bone cancer pain through the neuro-immune system: progress based on animal experiments. [PDF]

Front Neurol
Qi P, Zhou M, Han W, Li H, Min L, Li J, Sun Z, Yin H.   +7 more
europepmc   +1 more source

Comparative Effectiveness of Sildenafil versus Tadalafil as Companion Therapy to Endothelin Receptor Antagonists in Pulmonary Hypertension: A Systematic Review and Meta-Analysis of Invasive Hemodynamic Data

Antoine AbdelMassih, Nada AlSaqqa
openalex   +1 more source

Endothelin receptor blockade and nitric oxide bioactivity: [Cardiovascular Research 2001;49:146-151] [PDF]

, 2017
Barton, Matthias, Glodny, Bernhard
core  

Matching-adjusted indirect comparison of kidney function in patients with immunoglobulin A nephropathy treated with nefecon or sparsentan. [PDF]

J Comp Eff Res
Ngai C, Patel M, Kopiec A, Fu S, Hummel N.   +4 more
europepmc   +1 more source

Evaluation of Exercise Capacity in Fontan Patients and Effects of Pulmonary Vasodilators. [PDF]

Korean Circ J
Kim SH.
europepmc   +1 more source